These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 22818164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn's disease.
    Vannucchi V, Grazzini M, Pieralli F, Giannotta M, Biagioni C, Nozzoli C.
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):201-3. PubMed ID: 21725519
    [Abstract] [Full Text] [Related]

  • 3. Infliximab-induced psoriasis during therapy for Crohn's disease.
    Steinwurz F, Denadai R, Saad-Hossne R, Queiroz ML, Teixeira FV, Romiti R.
    J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
    [Abstract] [Full Text] [Related]

  • 4. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
    Mañosa M, Domènech E, Marín L, Olivé A, Zabana Y, Cabré E, Gassull MA.
    Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Systemic lupus erythematosus complicated by Crohn's disease: a case report and literature review.
    Yamashita H, Ueda Y, Kawaguchi H, Suzuki A, Takahashi Y, Kaneko H, Kano T, Mimori A.
    BMC Gastroenterol; 2012 Dec 05; 12():174. PubMed ID: 23216789
    [Abstract] [Full Text] [Related]

  • 11. Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?
    Kocharla L, Mongey AB.
    Lupus; 2009 Feb 05; 18(2):169-71. PubMed ID: 19151120
    [Abstract] [Full Text] [Related]

  • 12. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M, Beltrán B, Bastida G, Aguas M, Nos P.
    J Crohns Colitis; 2011 Apr 05; 5(2):157-61. PubMed ID: 21453886
    [Abstract] [Full Text] [Related]

  • 13. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.
    Subramanian S, Yajnik V, Sands BE, Cullen G, Korzenik JR.
    Inflamm Bowel Dis; 2011 Jan 05; 17(1):99-104. PubMed ID: 20629183
    [Abstract] [Full Text] [Related]

  • 14. Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab.
    Mounach A, Ghazi M, Nouijai A, Ghozlani I, Achemlal L, Bezza A, El Maghraoui A.
    Clin Exp Rheumatol; 2008 Jan 05; 26(6):1116-8. PubMed ID: 19210883
    [Abstract] [Full Text] [Related]

  • 15. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X, Club Rhumatismes et Inflammation.
    Arthritis Res Ther; 2005 Jan 05; 7(3):R545-51. PubMed ID: 15899041
    [Abstract] [Full Text] [Related]

  • 16. Use of infliximab and anti-infliximab antibody measurements to evaluate and optimize efficacy and safety of infliximab maintenance therapy in Crohn's disease.
    Steenholdt C.
    Dan Med J; 2013 Apr 05; 60(4):B4616. PubMed ID: 23651723
    [Abstract] [Full Text] [Related]

  • 17. Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.
    Famenini S, Wu JJ.
    J Drugs Dermatol; 2013 Aug 05; 12(8):939-43. PubMed ID: 23986169
    [Abstract] [Full Text] [Related]

  • 18. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
    Hukkinen M, Pakarinen MP, Piekkala M, Koivusalo A, Rintala R, Kolho KL.
    J Crohns Colitis; 2014 Aug 05; 8(8):756-62. PubMed ID: 24447625
    [Abstract] [Full Text] [Related]

  • 19. Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease.
    Han PD, Cohen RD.
    Drugs; 2004 Aug 05; 64(16):1767-77. PubMed ID: 15301561
    [Abstract] [Full Text] [Related]

  • 20. Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn's Disease.
    Loebenstein M, Schulberg JD.
    Gastroenterology; 2020 Jun 05; 158(8):2069-2071. PubMed ID: 31945355
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.